As both inflammation markers, SF and CRP, also predict adverse cardiovascular events, we recommend intervention studies that achieve high 25(OH)D concentrations to establish their combined benefits in terms of preventing cardiovascular disease among obese subjects. The gene discussed is CRP; the disease is cardiovascular disorder.